Literature DB >> 24996495

Melatonin and the circadian system: contributions to successful female reproduction.

Russel J Reiter1, Hiroshi Tamura2, Dun Xian Tan2, Xiao-Ying Xu2.   

Abstract

OBJECTIVE: To summarize the role of melatonin and circadian rhythms in determining optimal female reproductive physiology, especially at the peripheral level.
DESIGN: Databases were searched for the related English-language literature published up to March 1, 2014. Only papers in peer-reviewed journals are cited.
SETTING: Not applicable. PATIENT(S): Not applicable. INTERVENTION(S): Melatonin treatment, alterations of the normal light:dark cycle and light exposure at night. MAIN OUTCOME MEASURE(S): Melatonin levels in the blood and in the ovarian follicular fluid and melatonin synthesis, oxidative damage and circadian rhythm disturbances in peripheral reproductive organs. RESULT(S): The central circadian regulatory system is located in the suprachiasmatic nucleus (SCN). The output of this master clock is synchronized to 24 hours by the prevailing light-dark cycle. The SCN regulates rhythms in peripheral cells via the autonomic nervous system and it sends a neural message to the pineal gland where it controls the cyclic production of melatonin; after its release, the melatonin rhythm strengthens peripheral oscillators. Melatonin is also produced in the peripheral reproductive organs, including granulosa cells, the cumulus oophorus, and the oocyte. These cells, along with the blood, may contribute melatonin to the follicular fluid, which has melatonin levels higher than those in the blood. Melatonin is a powerful free radical scavenger and protects the oocyte from oxidative stress, especially at the time of ovulation. The cyclic levels of melatonin in the blood pass through the placenta and aid in the organization of the fetal SCN. In the absence of this synchronizing effect, the offspring may exhibit neurobehavioral deficits. Also, melatonin protects the developing fetus from oxidative stress. Melatonin produced in the placenta likewise may preserve the optimal function of this organ. CONCLUSION(S): Both stable circadian rhythms and cyclic melatonin availability are critical for optimal ovarian physiology and placental function. Because light exposure after darkness onset at night disrupts the master circadian clock and suppresses elevated nocturnal melatonin levels, light at night should be avoided.
Copyright © 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Circadian rhythms; fetus; melatonin; oocyte; placenta

Mesh:

Substances:

Year:  2014        PMID: 24996495     DOI: 10.1016/j.fertnstert.2014.06.014

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  51 in total

1.  The influences of sleep duration, chronotype, and nightwork on the ovarian cycle.

Authors:  Kara A Michels; Pauline Mendola; Karen C Schliep; Edwina H Yeung; Aijun Ye; Galit L Dunietz; Jean Wactawski-Wende; Keewan Kim; Joshua R Freeman; Enrique F Schisterman; Sunni L Mumford
Journal:  Chronobiol Int       Date:  2019-11-28       Impact factor: 2.877

2.  Melatonin protects against chronic stress-induced oxidative meiotic defects in mice MII oocytes by regulating SIRT1.

Authors:  Ying Guo; Junyan Sun; Shixia Bu; Boning Li; Qiuwan Zhang; Qian Wang; Dongmei Lai
Journal:  Cell Cycle       Date:  2020-05-26       Impact factor: 4.534

Review 3.  The Safety of Melatonin in Humans.

Authors:  Lars Peter Holst Andersen; Ismail Gögenur; Jacob Rosenberg; Russel J Reiter
Journal:  Clin Drug Investig       Date:  2016-03       Impact factor: 2.859

4.  Chronic Melatonin Treatment Prevents Memory Impairment Induced by Chronic Sleep Deprivation.

Authors:  Karem H Alzoubi; Fadia A Mayyas; Omar F Khabour; Fatima M Bani Salama; Farah H Alhashimi; Nizar M Mhaidat
Journal:  Mol Neurobiol       Date:  2015-06-18       Impact factor: 5.590

5.  Melatonin is involved in the modulation of the hypothalamic and pituitary activity in the South American plains vizcacha, Lagostomus maximus.

Authors:  Santiago Elías Charif; Pablo Ignacio Felipe Inserra; Alejandro Raúl Schmidt; Santiago Andrés Cortasa; Sofía Proietto; María Clara Corso; Julia Halperin; Noelia Paula Di Giorgio; Victoria Lux-Lantos; Alfredo Daniel Vitullo; Verónica Berta Dorfman
Journal:  J Comp Physiol B       Date:  2021-08-30       Impact factor: 2.200

6.  Melatonin Improves Quality of Repeated-Poor and Frozen-Thawed Embryos in Human, a Prospective Clinical Trial.

Authors:  Zhongjian Bao; Guangdong Li; Rongxiang Wang; Songguo Xue; Yong Zeng; Shoulong Deng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-13       Impact factor: 6.055

7.  The Effect of Melatonin on OCT4 Expression and Granulosa Cell Growth in Female Mice.

Authors:  Baoqiang Fu; Dai Heng; Ningxin Li; Xiaoshu Ma; Qiaozhi Wang; Yanzhou Yang; Cheng Zhang
Journal:  Reprod Sci       Date:  2021-11-04       Impact factor: 2.924

8.  Melatonin 1A and 1B Receptors' Expression Decreases in the Placenta of Women with Fetal Growth Restriction.

Authors:  Andrii M Berbets; Igor S Davydenko; Adrian M Barbe; Dmytro H Konkov; Olena M Albota; Oleksandr M Yuzko
Journal:  Reprod Sci       Date:  2020-08-17       Impact factor: 3.060

9.  The reduction in circulating levels of melatonin may be associated with the development of preeclampsia.

Authors:  K Zeng; Y Gao; J Wan; M Tong; A C Lee; M Zhao; Q Chen
Journal:  J Hum Hypertens       Date:  2016-06-02       Impact factor: 3.012

10.  Evaluation of Polymeric Matrix Loaded with Melatonin for Wound Dressing.

Authors:  Beata Kaczmarek-Szczepańska; Justyna Ostrowska; Justyna Kozłowska; Zofia Szota; Anna A Brożyna; Rita Dreier; Russel J Reiter; Andrzej T Slominski; Kerstin Steinbrink; Konrad Kleszczyński
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.